Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03834688
Title Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors PrECOG, LLC.

mantle cell lymphoma


Bendamustine + Rituximab + Venetoclax

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.